Lyell Immunopharma
LYEL
52 hedge funds and large institutions have $1.29B invested in Lyell Immunopharma in 2021 Q2 according to their latest regulatory filings, with 52 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
1.64% more ownership
Funds ownership: 0% → 1.64% (+1.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MM
MWG Management
Road Town, Tortola,
British Virgin Islands
|
+$333M |
| 2 |
A
Apoletto
Road Town, Tortola,
British Virgin Islands
|
+$249M |
| 3 |
FCMI
Foresite Capital Management IV
Larkspur,
California
|
+$218M |
| 4 |
AI
Alphabet Inc
Mountain View,
California
|
+$96.2M |
| 5 |
SM
SB Management
Abu Dhabi,
United Arab Emirates
|
+$57.4M |
Top Sellers
LYEL Hedge Fund Activity: Q2 2021 in Review
52 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Lyell Immunopharma (LYEL) for Q2 2021, worth a combined $1.29B.
Buyers outnumbered sellers: 52 funds opened new LYEL positions and 0 closed out — a net gain of 52 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was MWG Management, opening a new position worth an estimated $333M.
- 52 institutional investors held Lyell Immunopharma (LYEL) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $1.29B of Lyell Immunopharma stock for Q2 2021.
- 52 funds opened new Lyell Immunopharma positions in Q2 2021 and 0 closed out, a net change of +52 holders.
- The largest Lyell Immunopharma buyer in Q2 2021 was MWG Management, an estimated $333M added.
Based on aggregated 13F filings for Q2 2021.